✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Zenotech Laboratories Ltd.

ZENOTECH

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹278 Cr.
P/E
90.42

Zenotech Laboratories Ltd.

  • Zenotech Laboratorie
  • Jeevan Scientific
  • Vivo Bio Tech
  • TJI Pharma - Small Cap

FAQs on Zenotech Laboratories Ltd. Shareprice

Zenotech Laboratorie has given lower returns compared to its competitors.
Zenotech Laboratorie has grown at ~-1.52% over the last 8yrs while peers have grown at a median rate of -0.16%

Zenotech Laboratorie is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Zenotech Laboratorie is 89.89, while 3 year average PE is 46.53.
Also latest EV/EBITDA of Zenotech Laboratorie is 18.66 while 3yr average is 21.78.

View FAQ's On Business

Growth Table

  • Zenotech Laboratories Ltd.
  • Jeevan Scientific
  • Vivo Bio Tech

Balance Sheet

  • Zenotech Laboratories Ltd.
  • Jeevan Scientific
  • Vivo Bio Tech

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Zenotech Laboratories Ltd.
  • Jeevan Scientific
  • Vivo Bio Tech

Cash Flow

  • Zenotech Laboratories Ltd.
  • Jeevan Scientific
  • Vivo Bio Tech

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Zenotech Laboratories Ltd.
  • Jeevan Scientific
  • Vivo Bio Tech

Quarterly Results

  • Zenotech Laboratories Ltd.
  • Jeevan Scientific
  • Vivo Bio Tech

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Zenotech Laboratories Ltd. Financials

Balance sheet of Zenotech Laboratorie is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Zenotech Laboratorie is increasing.
Latest net debt of Zenotech Laboratorie is -₹31.74 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹53.4 Crs.

No, profit is decreasing.
The profit of Zenotech Laboratorie is ₹3.08 Crs for TTM, ₹5.61 Crs for Mar 2025 and ₹8.3 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zenotech Laboratorie latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech